Physician profile
Gary H Shaw
NPI 1013921154
$447.81
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $50.98 · 2021: $146 · 2022: $62.45 · 2023: $38.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $129.28 | 2019-2021 | |
| Akebia Therapeutics INC | $59.66 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.44 | 2023 | Lifevest |
| Otsuka America Pharmaceutical, INC. | $38.10 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $32.87 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $28.04 | 2019 | |
| Abbvie INC. | $27.64 | 2022 | |
| Alexion Pharmaceuticals, INC. | $24.25 | 2021 | |
| Boston Scientific Corporation | $20.74 | 2021 | |
| Aurinia Pharma U.S., INC. | $19.69 | 2022 | |
| Travere Therapeutics, INC. | $15.12 | 2022 | |
| Sunovion Pharmaceuticals INC. | $13.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.